Finance

Lists
ZVRA:NASDAQ
Zevra Therapeutics Inc
US$9,99
-1,87%
(-0,19) 1D
US$10,05
+0,60% (+0,060)
After hours
Closed: 2 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ZVRA...
Open
US$10,24
High
US$10,24
Low
US$9,84
Mkt. cap
593,24 ລ້ານ
Avg. vol.
914,18 ພັນ
Volume
951,87 ພັນ
P/E ratio
10,43
52-wk high
US$15,04
52-wk low
US$8,01
EPS
US$0,96
Beta
0,98
Shares outstanding
59,38 ລ້ານ
No. of employees
61
Open
US$10,24
High
US$10,24
Low
US$9,84
Mkt. cap
593,24 ລ້ານ
Avg. vol.
914,18 ພັນ
Volume
951,87 ພັນ
P/E ratio
10,43
52-wk high
US$15,04
52-wk low
US$8,01
EPS
US$0,96
Beta
0,98
Shares outstanding
59,38 ລ້ານ
No. of employees
61
News stories
From web sources and news partners
About Zevra Therapeutics Inc
CEO-
Employees61
Founded2006
Headquarters-
SectorPharmaceutical industry
Websitezevra.com
Analyst ratings
Based on 9 analysts giving stock ratings to ZVRA in the past 3 months
Strong buy
Buy
9
Hold
0
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for ZVRA in the last 3 months.
Highest
Current US$9,99
US$35,00 (+250,35%)
Average
US$25,25 (+152,75%)
Lowest
US$20,00 (+100,20%)
Analyst
Recommendation
Action
Price target
Projected
Date
Lachlan Hanbury Brown
William Blair
Buy
Maintained
-
-
09/30/2026
Brandon Folkes
H.C. Wainwright
Buy
Maintained
US$26,00
+160,3%
09/21/2026
Sumant Kulkarni
Canaccord Genuity
Buy
Reiterated
US$20,00
+100,2%
08/11/2026
Jason McCarthy
Maxim Group
Buy
Maintained
US$35,00
+250,4%
08/06/2026
Eddie Hickman
Guggenheim
Buy
Maintained
US$23,00
+130,2%
08/06/2026
Jonathan Aschoff
Roth MKM
Buy
Maintained
US$21,00
+110,2%
08/06/2026
Kambiz Yazdi
BTIG
Buy
Maintained
US$24,00
+140,2%
08/05/2026
Jason Butler
Citizens JMP
Buy
Maintained
US$28,00
+180,3%
08/06/2026
Sami Corwin
William Blair
Buy
Maintained
-
-
08/06/2026
Kristen Kluska
Cantor Fitzgerald
Buy
Maintained
US$25,00
+150,3%
08/05/2026
Unknown Analyst
Roth MKM
Buy
Maintained
US$21,00
+110,2%
05/07/2026
Last report
5 ສ.ຫ. 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
US$0,25 / US$0,18
+41,51%beat
Revenue / Est. (USD)
39,66 ລ້ານ / 34,84 ລ້ານ
+13,85%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
26,06 ລ້ານ
34,12 ລ້ານ
36,22 ລ້ານ
39,66 ລ້ານ
Cost of goods sold
1,24 ລ້ານ
1,52 ລ້ານ
1,90 ລ້ານ
1,52 ລ້ານ
Cost of revenue
1,24 ລ້ານ
1,52 ລ້ານ
1,90 ລ້ານ
1,52 ລ້ານ
Research and development expenses
3,43 ລ້ານ
2,52 ລ້ານ
4,39 ລ້ານ
4,49 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
16,94 ລ້ານ
20,45 ລ້ານ
20,78 ລ້ານ
16,56 ລ້ານ
Operating expense
20,68 ລ້ານ
23,29 ລ້ານ
25,49 ລ້ານ
21,36 ລ້ານ
Total operating expenses
21,92 ລ້ານ
24,81 ລ້ານ
27,39 ລ້ານ
22,89 ລ້ານ
Operating income
4,14 ລ້ານ
9,32 ລ້ານ
8,83 ລ້ານ
16,78 ລ້ານ
Other non operating income
-5,51 ລ້ານ
3,56 ລ້ານ
-6,25 ລ້ານ
-6,41 ລ້ານ
EBT including unusual items
-977,00 ພັນ
12,67 ລ້ານ
44,80 ລ້ານ
12,79 ລ້ານ
EBT excluding unusual items
-1,10 ລ້ານ
12,64 ລ້ານ
4,46 ລ້ານ
12,93 ລ້ານ
Income tax expense
-433,00 ພັນ
501,00 ພັນ
6,91 ລ້ານ
4,04 ລ້ານ
Effective tax rate
44,32%
3,96%
15,43%
31,59%
Other operating expenses
-
-
-
-
Net income
-544,00 ພັນ
12,16 ລ້ານ
37,89 ລ້ານ
8,75 ລ້ານ
Net profit margin
-2,09%
35,65%
104,61%
22,07%
Earnings per share
-0,01
0,19
0,18
0,25
Interest and investment income
2,31 ລ້ານ
1,71 ລ້ານ
3,59 ລ້ານ
2,56 ລ້ານ
Interest expense
-2,05 ລ້ານ
-1,95 ລ້ານ
-1,71 ລ້ານ
-
Net interest expenses
262,00 ພັນ
-236,00 ພັນ
1,88 ລ້ານ
2,56 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
4,54 ລ້ານ
9,68 ລ້ານ
9,20 ລ້ານ
17,14 ລ້ານ
Gain or loss from assets sale
-
63,00 ພັນ
-43,31 ລ້ານ
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
ແອັບຂອງ Google